Kestra Medical Technologies (NASDAQ:KMTS) Hits New 52-Week Low - Time to Sell?

Kestra Medical Technologies, Ltd. (NASDAQ:KMTS - Get Free Report)'s share price reached a new 52-week low during trading on Tuesday . The stock traded as low as $19.84 and last traded at $19.97, with a volume of 11826 shares traded. The stock had previously closed at $20.68.

Analyst Upgrades and Downgrades

KMTS has been the topic of a number of analyst reports. Piper Sandler initiated coverage on Kestra Medical Technologies in a research report on Monday, March 31st. They issued an "overweight" rating and a $27.00 price target on the stock. Wells Fargo & Company assumed coverage on shares of Kestra Medical Technologies in a research report on Monday, March 31st. They set an "overweight" rating and a $28.00 target price for the company. Bank of America began coverage on shares of Kestra Medical Technologies in a research report on Monday, March 31st. They issued a "buy" rating and a $30.00 price target on the stock. The Goldman Sachs Group dropped their price objective on shares of Kestra Medical Technologies from $24.00 to $23.00 and set a "neutral" rating for the company in a report on Wednesday, April 16th. Finally, Stifel Nicolaus started coverage on Kestra Medical Technologies in a report on Monday, March 31st. They issued a "buy" rating and a $28.00 target price on the stock. One analyst has rated the stock with a hold rating and five have issued a buy rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $27.50.

Kestra Medical Technologies Trading Up 3.3%

The stock has a 50-day moving average of $23.24.

Kestra Medical Technologies (NASDAQ:KMTS - Get Free Report) last released its earnings results on Monday, April 14th. The company reported ($1.25) earnings per share for the quarter, missing analysts' consensus estimates of ($0.64) by ($0.61). During the same period in the prior year, the company posted ($1.18) earnings per share.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the stock. Quarry LP acquired a new position in Kestra Medical Technologies in the first quarter valued at about $33,000. Virtu Financial LLC acquired a new stake in shares of Kestra Medical Technologies in the 1st quarter valued at approximately $210,000. Armistice Capital LLC bought a new position in Kestra Medical Technologies during the 1st quarter worth approximately $312,000. Zimmer Partners LP acquired a new position in Kestra Medical Technologies during the first quarter valued at approximately $374,000. Finally, Russell Investments Group Ltd. bought a new stake in Kestra Medical Technologies in the first quarter valued at approximately $457,000.

Kestra Medical Technologies Company Profile

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.